共 50 条
- [1] Impact of age on outcomes of Japanese patients with rheumatoid arthritis treated with infliximab: The post marketing surveillance trial. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S421 - S421
- [2] Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S422 - S422
- [4] The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S426 - S426
- [6] Impact of gender on outcome of Japanese patients with rheumatoid arthritis: The post marketing surveillance trial. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S55 - S55
- [9] Tuberculosis in patients treated with vedolizumab: clinical trial and post-marketing case series JOURNAL OF CROHNS & COLITIS, 2017, 11 : S410 - S411